Study of Imaging and Molecular Biomarkers in Uncomplicated Rhegmatogenous Retinal Detachment
This study focuses on a serious eye condition called rhegmatogenous retinal detachment (RRD). After surgery for this condition, some patients develop a complication called proliferative vitreoretinopathy (PVR), which can lead to more vision problems. We want to understand why PVR develops in some people and not others. Researchers will analyse fluid from the eye and use advanced imaging and artificial intelligence to find clues. The aim is to create tools that help doctors predict who is at higher risk of PVR. This will allow for earlier detection and better treatments in the future, ultimately improving outcomes for patients with retinal detachment.
At a glance
What is this study about?
This research study is looking for a better understanding of a serious eye problem called rhegmatogenous retinal detachment (RRD). This happens when the light-sensitive lining at the back of your eye, called the retina, pulls away from its normal position. If not treated quickly, it can lead to permanent vision loss. The usual treatment is surgery to reattach the retina.
Unfortunately, even after successful surgery, about 15-20% of patients develop another problem called proliferative vitreoretinopathy (PVR). This is like a scarring process inside the eye that can cause the retina to detach again, leading to more complications. At the moment, it's hard for doctors to know who will develop PVR and who won't. This study aims to change that.
Researchers will collect fluid from the eye during surgery and use special scans and advanced computer programs (artificial intelligence) to look for signs or 'biomarkers' that might predict PVR. By identifying these early warning signs, doctors hope to develop new ways to identify patients at high risk and offer them more tailored care, potentially preventing PVR or treating it sooner. This could significantly improve the chances of a good outcome for people with retinal detachment.
Key takeaways
- This study aims to understand why some people develop complications after retinal detachment surgery.
- It uses advanced eye scans and fluid analysis to find early warning signs.
- Participation involves routine care plus extra non-invasive eye checks and a fluid sample during surgery.
- The goal is to improve future diagnosis and treatment for a serious eye problem.
- Your decision to join or leave the study will not affect your medical care.
Who may be eligible?
This study is looking for adults aged 18 or older who have been diagnosed with a straightforward rhegmatogenous retinal detachment that doesn't yet have any signs of the scarring complication called PVR. Essentially, we are looking for people undergoing their first surgery for this type of retinal detachment.
There are several reasons why someone might not be able to join the study. These include being under 18 or not able to understand and agree to participate. People who have had previous eye surgery for a retinal problem, or those with other significant eye conditions like severe diabetic eye disease, cannot take part.
Also, if your retinal detachment is caused by an infection or a birth defect, or if you can't have a clear view of the back of your eye, you wouldn't be suitable for this study. The research is specifically for a particular type of retinal detachment without pre-existing complications.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Have you been diagnosed with a 'rhegmatogenous retinal detachment' that doesn't have other complications?
- Have you NOT had previous eye surgery for a retinal problem?
- Do you NOT have other serious eye conditions, like severe diabetic eye disease?
- Can you understand and agree to participate in a research study?
What does participation involve?
If you decide to take part in this study, you will receive the standard care for your retinal detachment, just as any other patient would. This includes pre-operative checks and assessments, the retinal detachment surgery itself, and follow-up appointments after your surgery.
In addition to your usual care, there will be some extra steps. Before and after your surgery, you will have additional non-invasive eye scans. These include detailed pictures of the front and back of your eye (anterior chamber flare, wide-field retina), and specific scans of your macula (OCT and OCT-angiography). These scans are painless and don't involve touching your eye directly. You will also be asked if you agree for a tiny amount of fluid from your eye to be collected during your surgery. This fluid, called vitreous fluid, will be analysed in a lab to look for certain markers. All these extra assessments will take place over a period of about three months after your surgery.
Potential risks and benefits
Locations (1)
- Moorfields Eye HospitalVerified postcodeLondon, United Kingdom
Common questions
What is retinal detachment?
It's when the retina, the light-sensitive part at the back of your eye, pulls away from its usual position. It needs quick treatment to save your vision.
What is PVR?
PVR stands for proliferative vitreoretinopathy. It's a scarring process that can happen inside the eye after retinal detachment surgery, sometimes causing the retina to detach again.
Will I get a new treatment in this study?
No, this study is about understanding the condition better, not testing new treatments. You will receive standard care for your eye condition.
What is 'vitreous fluid'?
It's the jelly-like substance that fills the inside of your eye. A tiny amount can be collected during surgery for analysis.
How long will I be involved in the study?
Your involvement, including extra scans, will generally be for about three months after your surgery.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.